Condition: Non-Small Cell Lung Cancer · Carcinoma, Squamous Cell · Adenocarcinoma · Sponsor: University of Birmingham
The trial consists of a series of parallel multi-centre single arm phase II trial arms, each testing an experimental targeted drug in a population stratified by multiple pre-specified actionable target putative biomarkers. The primary objective is to evaluate whether there is a signal of activity in each drug-(putative)biomarker cohort separately. A Bayesian adaptive design is adopted to achieve this objective and statistical details are given in the Protocol.
This description comes directly from the study's public registry record.
No contact information is available for this study as per the public registry record.
Always discuss trial participation with your own doctor first.
| Aberdeen Royal Infirmary | Aberdeen, United Kingdom | — |
| Belfast City Hospital, Belfast Health and Social Care Trust | Belfast, United Kingdom | — |
| Queen Elizabeth Hospital Birmingham, University Hospitals Birmingham NHS Foundation Trust | Birmingham, United Kingdom | — |
| Birmingham Heartlands Hospital, Heart of England NHS Foundation Trust | Birmingham, United Kingdom | — |
| University Hospitals Bristol NHS Foundation Trust | Bristol, United Kingdom | — |
| Addenbrooke's Hospital, Cambridge University Hospitals NHS Foundation Trust | Cambridge, United Kingdom | — |
| Velindre Cancer Centre, Velindre NHS Trust | Cardiff, United Kingdom | — |
| Colchester General Hospital | Colchester, United Kingdom | — |
| Edinburgh Cancer Centre, Western General Hospital | Edinburgh, United Kingdom | — |
| Royal Devon and Exeter Hospital | Exeter, United Kingdom | — |
| Beatson West of Scotland Cancer Centre | Glasgow, United Kingdom | — |
| St. James' University Hospital, Leeds Teaching Hospital NHS Trust | Leeds, United Kingdom | — |
+ 13 more locations — full list on the registry record.
Save your interest here for when the public record changes — results posted, or the study's status changes. Email alerts for this study aren't switched on yet.
We keep this only about this public record, and never email you without alerts being switched on. Want it removed at any time? Email hello@eichor.com. Never medical advice. By subscribing you agree to our Terms of Use and Privacy Policy.